| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.53B | 2.37B | 1.99B | 2.22B | 1.92B |
| Gross Profit | 387.50M | 363.31M | 268.60M | 262.69M | 282.20M |
| EBITDA | 98.06M | 153.90M | 130.89M | 159.37M | 155.31M |
| Net Income | 50.29M | 46.68M | 36.42M | 59.91M | 51.47M |
Balance Sheet | |||||
| Total Assets | 2.94B | 2.76B | 2.40B | 2.72B | 2.43B |
| Cash, Cash Equivalents and Short-Term Investments | 891.95M | 378.95M | 640.92M | 316.65M | 454.33M |
| Total Debt | 1.21B | 385.42M | 278.74M | 457.75M | 343.50M |
| Total Liabilities | 1.99B | 1.86B | 1.53B | 1.90B | 1.61B |
| Stockholders Equity | 948.21M | 893.37M | 866.52M | 825.29M | 818.48M |
Cash Flow | |||||
| Free Cash Flow | 161.56M | 96.56M | -242.39M | 269.12M | 230.06M |
| Operating Cash Flow | 228.66M | 162.22M | -135.94M | 319.78M | 255.42M |
| Investing Cash Flow | -218.54M | -260.06M | 432.18M | -295.92M | -169.60M |
| Financing Cash Flow | 10.50M | 50.74M | -192.28M | 137.18M | -77.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$228.00M | 32.98 | 1.16% | 5.22% | -11.32% | -85.52% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | HK$127.44M | 2.97 | 5.36% | ― | 6.65% | 7.77% | |
48 Neutral | HK$186.12M | -4.29 | -4.05% | ― | 6.62% | 70.90% | |
47 Neutral | HK$378.66M | 59.54 | 0.41% | 0.63% | 2.35% | -20.12% | |
42 Neutral | HK$64.33M | -0.66 | -1.86% | ― | -9.99% | -58.72% |